Last reviewed 2026-04-19 · How we verify

GA-GCB

Shire · Phase 1 active Small molecule

At a glance

Generic name	GA-GCB
Also known as	VPRIV®, velaglucerase alfa, gene-activated glucocerebrosidase, DRX008
Sponsor	Shire
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GA-GCB CI brief — competitive landscape report
GA-GCB updates RSS · CI watch RSS
Shire portfolio CI